SNF

PointClickCare and C3HIE Collaborate to Enable Smoother and Safer Care Transitions for Patients Across the State of Texas

Retrieved on: 
onsdag, maj 29, 2024
Technology, Hospitals, Health Technology, Professional Services, Software, Practice Management, Managed Care, Data Analytics, Health, Data Management, Partnership, Patient, Learning, Hospital, Organization, EDEN, SNF, Senior, ADT, Emergency department, Acos, History, Nursing

PointClickCare , a leading healthcare technology platform enabling meaningful care collaboration and real-time patient insights, and C3HIE , a community partner offering additional critical interoperability and care coordination services, announced today its first direct partnership.

Key Points: 
  • PointClickCare , a leading healthcare technology platform enabling meaningful care collaboration and real-time patient insights, and C3HIE , a community partner offering additional critical interoperability and care coordination services, announced today its first direct partnership.
  • Together, the organizations are working towards a goal of improving health outcomes patients across the state of Texas and ensuring a more connected care experience at every stage of the patient healthcare journey.
  • This collaboration will further enable smoother and safer care transitions by bringing C3HIE’s admission, discharge, and transfer (ADT) data to PointClickCare’s comprehensive platform, while adding PointClickCare's expansive Skilled Nursing Facility (SNF) data into the C3HIE network.
  • This partnership aligns with C3HIE's mission of making the healthcare community more connected and collaborative," says Phil Beckett , CEO, C3HIE.

PointClickCare Now Supports Over 32.7 Million Californians with Expanded Care Collaboration Network

Retrieved on: 
onsdag, maj 15, 2024
Health, Technology, Hospitals, Practice Management, Managed Care, Software, General Health, Patient, Learning, Hospital, General number field sieve, SMART, Substance use disorder, FHIR, Audio signal processing, ECM, SNF, Collection, Social, Senior, Acos, EHR, Workflow, L.A. Care Health Plan, Communication, ED, High, Bed, Triage, Nursing

PointClickCare, a leading healthcare technology platform enabling meaningful care collaboration and real‐time patient insights, is announcing the details of its continued investment and expansion across the state of California.

Key Points: 
  • PointClickCare, a leading healthcare technology platform enabling meaningful care collaboration and real‐time patient insights, is announcing the details of its continued investment and expansion across the state of California.
  • Through the integration and standardization of California’s largest collection of encounter and clinical data, PointClickCare is trailblazing the path to more streamlined care for all patients statewide.
  • With a Care Collaboration Network that covers 182 hospitals, 229 ambulatory clinics, 1,054 skilled nursing facilities (SNFs), and 17 health plans, the company’s network now supports over 32.7 million Californians, and 55% acute and 78% SNF providers across the state that currently share data through its platform.
  • Health Plans and ECM providers across the state can harness the power of care collaboration across the entire care network – and the results are tangible.

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Retrieved on: 
torsdag, maj 9, 2024
SNF, FOLFIRINOX, DOI, Blood, Pancreatic cancer, Poster, TILS, Immunotherapy, TSX, PR, MD, Tumor microenvironment, AB, ONC, Roche, PDAC, Cancer, Patient, Pancreatic Cancer Action Network, AIO, Medicine, SWI, MMSc, Ethics, PD, Therapy, SAN, Anal cancer, TME, Pharmaceutical industry

SAN DIEGO and CALGARY, AB, May 9, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, will commence enrollment into a new GOBLET study pancreatic cancer cohort following both German regulatory and ethics approvals. This cohort will evaluate pelareorep in combination with modified FOLFIRINOX (mFOLFIRINOX) with or without the PD-L1 immune checkpoint inhibitor atezolizumab (Tecentriq®) in newly diagnosed patients with pancreatic ductal adenocarcinoma (PDAC). It is supported by a US$5M Therapeutic Accelerator Award from the Pancreatic Cancer Action Network (PanCAN), an innovative program established to accelerate the development of new treatments for pancreatic cancer. The chemotherapy regimens of mFOLFIRINOX or gemcitabine + nab-paclitaxel are the two most common standards of care for pancreatic cancer.1 Oncolytics has already reported data with the combination of gemcitabine and nab-paclitaxel (link to the PR, link to the poster) that surpassed historical outcomes.2-5 Positive results from a combination with mFOLFIRINOX could greatly enhance pelareorep's potential in addressing pancreatic cancer.

Key Points: 
  • This cohort will evaluate pelareorep in combination with modified FOLFIRINOX (mFOLFIRINOX) with or without the PD-L1 immune checkpoint inhibitor atezolizumab (Tecentriq®) in newly diagnosed patients with pancreatic ductal adenocarcinoma (PDAC).
  • It is supported by a US$5M Therapeutic Accelerator Award from the Pancreatic Cancer Action Network (PanCAN), an innovative program established to accelerate the development of new treatments for pancreatic cancer.
  • "Oncolytics is pleased to announce receipt of regulatory clearance to initiate the mFOLFIRINOX cohort in patients with newly diagnosed metastatic PDAC.
  • "We believe that working with PanCAN will help to further enrich Oncolytics' clinical relationships with the pancreatic cancer community.

Sabra Reports First Quarter 2024 Results; Reiterates 2024 Guidance

Retrieved on: 
onsdag, maj 8, 2024
REIT, General Health, Health, Commercial Building & Real Estate, Construction & Property, Acquisition, SHOP, Webcast, SNF, ID, NOI, Investment, URL, Growth, Chair, ATM

Trailing-twelve-month SNF coverage saw a healthy 0.06x increase sequentially, to 1.79x, when excluding the impact of Provider Relief Funds.

Key Points: 
  • Trailing-twelve-month SNF coverage saw a healthy 0.06x increase sequentially, to 1.79x, when excluding the impact of Provider Relief Funds.
  • Our SHOP portfolio continues to improve, and this quarter’s results - which faced a challenging year-over-year comp - are in line with our expectations embedded in guidance.
  • A conference call with a simultaneous webcast to discuss the 2024 first quarter results will be held on Thursday, May 9, 2024, at 10:00 am Pacific Time.
  • The Company’s supplemental information package for the first quarter will also be available on the Company’s website in the “Investors” section.

A 40-Bed Physical Rehab Hospital in N.E. San Antonio, Texas is Announced Under Construction by Everest Rehabilitation Hospitals (their 17th location and 3rd in the city)

Retrieved on: 
onsdag, maj 8, 2024
Interstate Highway System, SNF, Stroke, Interstate 35, Hospital, City, Rehabilitation, Trauma, Television, Environment, Amputation, Patient, Physician, Health, Brain, Quality of life, SAN

DALLAS and SAN ANTONIO, May 8, 2024 /PRNewswire-PRWeb/ -- Today, Everest Rehabilitation Hospitals announced plans to construct a 40-bed inpatient physical rehabilitation hospital in N.E. San Antonio, specifically in Live Oak, Texas will be Everest's third location in the San Antonio Metroplex.

Key Points: 
  • San Antonio (Live Oak), TX as its latest location for yet another modern physical rehabilitation hospital in the San Antonio area.
  • DALLAS and SAN ANTONIO, May 8, 2024 /PRNewswire-PRWeb/ -- Today, Everest Rehabilitation Hospitals announced plans to construct a 40-bed inpatient physical rehabilitation hospital in N.E.
  • San Antonio, specifically in Live Oak, Texas will be Everest's third location in the San Antonio Metroplex.
  • The hospital is the latest in Everest's construction of modern inpatient physical rehabilitation hospitals.

Dwight Capital & Dwight Mortgage Trust Close $152.5MM in Seniors Housing During Q1 2024

Retrieved on: 
torsdag, maj 2, 2024
Commercial Building & Real Estate, Construction & Property, Finance, Banking, Professional Services, Urban Planning, REIT, Residential Building & Real Estate, SNF, ALF, Capital, HUD, DMT, General number field sieve, Acquisition, Financial services

Dwight Capital and its affiliate REIT, Dwight Mortgage Trust (“DMT”), financed $152.5MM in seniors housing during Q1 2024.

Key Points: 
  • Dwight Capital and its affiliate REIT, Dwight Mortgage Trust (“DMT”), financed $152.5MM in seniors housing during Q1 2024.
  • DMT closed a $44MM bridge acquisition loan for a 369-bed SNF in the Southwest U.S.
  • These HUD loans refinanced existing bridge loans provided by Dwight Mortgage Trust in December 2022.
  • Some other notable Q1 2024 transactions:
    $24.6MM bridge acquisition loan for a 369-bed SNF in New Jersey.

ReNew Health to Pay $7 Million to Settle First-of-its-Kind COVID-19 False Claims Act Case

Retrieved on: 
tisdag, april 30, 2024
SNF, Courage, CMS, Person, Learning, Pneumonia, State, Reed, Nursing, Medicaid, Medicare (United States), False Claims Act, Injury, Senior, COVID-19, Splenic infarction, Medicare, Judgement, Government, Pharmaceutical industry

MINNEAPOLIS, Minn., April 29, 2024 /PRNewswire-PRWeb/ -- Zimmerman Reed announced today that the United States and the State of California reached a $7 million settlement with ReNew Health Group LLC, ReNew Health Consulting Services LLC, and its owner-CEO and its COO to resolve False Claims Act allegations filed by Zimmerman Reed's whistleblower clients. ReNew Health, the owner and operator of dozens of nursing facilities throughout California, allegedly submitted millions of dollars of fraudulent claims to Medicare and California Medicaid since March 2020 under a scheme involving a COVID-19 waiver program.

Key Points: 
  • Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program.
  • "This case emphasizes the vital contribution that whistleblowers can make in exposing healthcare fraud," said June Hoidal, chair of Zimmerman Reed's Whistleblower practice.
  • "The courage of our clients who reported improper Medicare and Medicaid claims was instrumental in bringing this case to light and securing a just result."
  • The federal False Claims Act and its state law equivalents empower private citizens to sue on the government's behalf against persons who present false claims for payment under government contracts or programs.

Curve Health and MindCare Forge Strategic Partnership to Elevate Behavioral Health Services in Skilled Nursing Facilities

Retrieved on: 
fredag, april 26, 2024
SNF, Nursing home, Partnership, Quality of life, Mental health, Health, Long-term care, Nursing

By joining forces, Curve Health and MindCare aim to develop and implement innovative solutions specifically designed to address the behavioral health challenges encountered in SNFs.

Key Points: 
  • By joining forces, Curve Health and MindCare aim to develop and implement innovative solutions specifically designed to address the behavioral health challenges encountered in SNFs.
  • "We are excited to collaborate with MindCare to enhance behavioral health services within Skilled Nursing Facilities," said Matt Michela, CEO of Curve Health.
  • Through this partnership, Curve Health and MindCare will equip SNFs with the tools and resources needed to address the growing demand for behavioral health services among residents.
  • "We are thrilled to partner with Curve Health to elevate behavioral health services within Skilled Nursing Facilities," said Tana Whitt, Chief Clinical Officer of MindCare.

Amedisys Reports First Quarter 2024 Financial Results

Retrieved on: 
onsdag, april 24, 2024
SNF, Hospital, Hospice, Depreciation, Patient, Physician, Conditional sentence, UnitedHealth Group, Rehabilitation, Bank statement, GAAP, Music

BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.

Key Points: 
  • BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.
  • The supplemental slides provided in connection with the first quarter 2024 earnings release can be found on the Investor Relations page of our website.
  • In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the first quarter results.
  • These non-GAAP financial measures should be considered in addition to, and not more meaningful than or as an alternative to, the GAAP financial measures presented in this earnings release and the company’s financial statements.

Mining Chemicals Market Projected to Reach $15.43 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
måndag, april 22, 2024
Copper, SNF, Uranium, Collector, Evonik Industries, Metal, Mineral, Ecolab, Table, Typesetting, Research, Coal, Water, Intelligence, Dust, Gold, Extreme metal, Nickel, Mining, Growth

The mining chemicals sector is experiencing robust expansion, propelled by the increasing demand for minerals and metals and escalating mining operations worldwide.

Key Points: 
  • The mining chemicals sector is experiencing robust expansion, propelled by the increasing demand for minerals and metals and escalating mining operations worldwide.
  • The Asia-Pacific region showcases significant mining activities and a push for greater mineral extraction efficiency emphasized by a commitment to research and development for greener, more efficient mining chemicals.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Mining Chemicals Market.
  • "Dive into the Mining Chemicals Market Landscape: Explore 185 Pages of Insights, 292 Tables, and 22 Figures"